尿,

Orhan Efe1, Ayman Al Jurdi1, Morgan Mabey Eiting2

  • 1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.

Frontiers in immunology
|January 7, 2025
PubMed
概括

将蛋白尿症的移植接受者从氨抑制剂转换为贝拉塔cept,显示蛋白尿症减少了53%. 这种转换策略有助于在五年内保持脏全移植功能.